Inogen INGN
NASDAQ INGN
$5.27 +0.04 (+0.77%)
As of: Sep 9, 2026 · 3:59 PM EDT

Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026)

Inogen's (INGN) quarterly Non-Current Deferred Tax Liability came in at $6.5 million in Q2 2026, down 18.43% year-over-year from $8.0 million in Q2 2025, and down 1.32% quarter-over-quarter from $6.6 million in Q1 2026.

Analysis

Inogen (INGN) Non-Current Deferred Tax Liability (2017 - 2026) Analysis & Trends

Inogen (INGN) has reported Non-Current Deferred Tax Liability for 10 consecutive years, with $6.5 million the latest figure, recorded in Q2 2026.

  • On a quarterly basis, Non-Current Deferred Tax Liability fell 18.43% year-over-year to $6.5 million in Q2 2026; TTM through Jun 2026 was $6.5 million, a 18.43% decrease from a year earlier, with the FY2025 full-year figure at $6.7 million, down 2.86% from the prior year.
  • Non-Current Deferred Tax Liability was $6.5 million for Q2 2026 at Inogen, down from $6.6 million in the prior quarter.
  • Over five years, Non-Current Deferred Tax Liability peaked at $20.1 million in Q4 2023 and troughed at $6.5 million in Q2 2026.
  • A 5-year average of $9.0 million and a median of $8.0 million in 2025 frame the typical range for Non-Current Deferred Tax Liability.
  • Across the five-year window, Non-Current Deferred Tax Liability surged 43.83% in 2023 and plunged 65.37% in 2024, its largest moves.
  • Over 5 years, Non-Current Deferred Tax Liability stood at $14.0 million in 2022, then surged by 43.83% to $20.1 million in 2023, then sank by 65.37% to $6.9 million in 2024, then slipped by 2.86% to $6.7 million in 2025, then decreased by 3.91% to $6.5 million in 2026.
  • The last three Non-Current Deferred Tax Liability figures came in at $6.5 million (Q2 2026), $6.6 million (Q1 2026), and $6.7 million (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 183.04 Bn 177.44 Bn 7.27 Bn
2 Intuitive Surgical 125.02 Bn 119.81 Bn 1.96 Bn
3 Medtronic 117.84 Bn 109.02 Bn 6.34 Bn
4 Stryker 105.50 Bn 102.02 Bn 4.50 Bn
5 Boston Scientific 66.27 Bn 65.73 Bn 3.85 Bn
6 Edwards Lifesciences 49.60 Bn 45.35 Bn 1.35 Bn
7 Alcon 33.70 Bn 32.24 Bn 1.68 Bn
8 Dexcom 32.06 Bn 30.11 Bn 830.00 Mn
9 Steris 21.02 Bn 20.54 Bn 684.20 Mn
10 Inogen 142.58 Mn 37.04 Mn 43.27 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 6.49 Mn
Mar 31, 2026 6.57 Mn
Dec 31, 2025 6.75 Mn
Sep 30, 2025 7.89 Mn
Jun 30, 2025 7.95 Mn
Mar 31, 2025 7.41 Mn
Dec 31, 2024 6.95 Mn
Sep 30, 2024 8.38 Mn
Jun 30, 2024 8.07 Mn
Mar 31, 2024 8.15 Mn
Dec 31, 2023 20.07 Mn
Sep 30, 2023 8.42 Mn
Dec 31, 2022 13.95 Mn
Sep 30, 2021 24,000.00
Jun 30, 2021 25,000.00
Mar 31, 2021 24,000.00
Dec 31, 2020 25,000.00
Sep 30, 2020 91,000.00
Mar 31, 2020 85,000.00
Dec 31, 2019 87,000.00